middle.news
TrivarX Secures FDA Backing for Major Depression AI Screening Trial
7:03pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
TrivarX Secures FDA Backing for Major Depression AI Screening Trial
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
FDA endorses TrivarX's adaptive pivotal trial design for MEB-001
Trial to recruit at least 563 patients across multiple US sleep clinics
MEB-001 algorithm previously showed 87% sensitivity and 72% specificity
Engagement with prominent hospitals progressing to secure high-volume sites
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Trivarx (ASX:TRI)
OPEN ARTICLE